Packages (Simulation)
Reagent Preparation
Image (I)
-
Results demonstration
Image (II)
-
Typical Standard Curve
Quality Guarantee
Instruction Manual
Certificate
CLIA Kit for Docosahexaenoic Acid (DHA)
Doconexent; Cervonic Acid
- Product No.CCO623Ge
- Organism SpeciesPan-species (General) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range3.9-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.5pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 755
US$ 1078
US$ 4851
US$ 9163
US$ 75460
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Docosahexaenoic Acid (DHA).
No significant cross-reactivity or interference between Docosahexaenoic Acid (DHA) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of Docosahexaenoic Acid (DHA) and the recovery rates were calculated by comparing the measured value to the expected amount of Docosahexaenoic Acid (DHA) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 84-104 | 88 |
| EDTA plasma(n=5) | 92-104 | 97 |
| heparin plasma(n=5) | 85-101 | 90 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Docosahexaenoic Acid (DHA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Docosahexaenoic Acid (DHA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Docosahexaenoic Acid (DHA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 80-105% | 78-97% | 80-103% | 93-102% |
| EDTA plasma(n=5) | 82-95% | 80-97% | 92-99% | 78-104% |
| heparin plasma(n=5) | 78-97% | 85-92% | 93-101% | 88-96% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| Substrate A | 1×10mL | Substrate B | 1×2mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Iranian Journal of Kidney Diseases | Clinical Characterization of Serum Docosahexaenoic Acid and Its Relationship With Inflammation Factors in Patients With Diabetic Nephropathy Pubmed:29507271 |
| Journal of Experimental & Clinical Cancer Research | MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2 Pubmed: 31856871 |
| J Agric Food Chem | Novel Nanoliposome Codelivered DHA and Anthocyanidin: Characterization, In Vitro Infant Digestibility, and Improved Cell Uptake 34344151 |
| Catalog No. | Related products for research use of Pan-species (General) Organism species | Applications (RESEARCH USE ONLY!) |
| CPO623Ge11 | BSA Conjugated Docosahexaenoic Acid (DHA) | Immunogen; SDS-PAGE; WB. |
| CPO623Ge21 | OVA Conjugated Docosahexaenoic Acid (DHA) | Immunogen; SDS-PAGE; WB. |
| PAO623Ge01 | Polyclonal Antibody to Docosahexaenoic Acid (DHA) | ELISA, CLIA. / IHC-Fr, ICC, IP (predicted). |
| CEO623Ge | ELISA Kit for Docosahexaenoic Acid (DHA) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CCO623Ge | CLIA Kit for Docosahexaenoic Acid (DHA) | Chemiluminescent immunoassay for Antigen Detection. |
| LMO623Ge | Multiplex Assay Kit for Docosahexaenoic Acid (DHA) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |